ID   PA2G5_RAT               Reviewed;         137 AA.
AC   P51433; Q6DQ96;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Phospholipase A2 group V;
DE            EC=3.1.1.4 {ECO:0000250|UniProtKB:P39877, ECO:0000250|UniProtKB:P97391};
DE   AltName: Full=PLA2-10;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 5;
DE   Flags: Precursor;
GN   Name=Pla2g5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7947992; DOI=10.1016/0005-2760(94)90099-x;
RA   Chen J., Engle S.J., Seilhamer J.J., Tischfield J.A.;
RT   "Cloning, expression and partial characterization of a novel rat
RT   phospholipase A2.";
RL   Biochim. Biophys. Acta 1215:115-120(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Ovary;
RA   Liang N.S., Su Q.B., Li Y., Yang F., Lu Y., Xie Y.A.;
RT   "Cloning and sequence determination of rat group V phospholipase A2 from
RT   ovary.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily
CC       targets extracellular phospholipids. Hydrolyzes the ester bond of the
CC       fatty acyl group attached at sn-2 position of phospholipids
CC       (phospholipase A2 activity), preferentially releasing fatty acyl groups
CC       with a low degree of unsaturation such as oleoyl (C18:1) and linoleoyl
CC       (C18:2) groups (By similarity). Hydrolyzes low-density lipoprotein
CC       (LDL) phospholipids releasing unsaturated fatty acids that drive
CC       macrophage polarization toward an M2 phenotype (By similarity). May act
CC       in an autocrine and paracrine manner. Contributes to lipid remodeling
CC       of cellular membranes at different subcellular locations and generation
CC       of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty
CC       acyl chains of cardiolipin, a major component of the inner membrane of
CC       mitochondria and bacterial membranes. Promotes phagocytosis of bacteria
CC       in macrophages through production of lysophosphatidylethanolamines.
CC       Displays bactericidal activity against Gram-positive bacteria by
CC       directly hydrolyzing phospholipids of the bacterial membrane (By
CC       similarity). Promotes phagocytosis and killing of ingested fungi likely
CC       through controlling phagosome-lysosome fusion and phagosome maturation
CC       (By similarity). Plays a role in biosynthesis of cysteinyl leukotrienes
CC       (CysLTs) in myeloid cells. In eosinophils, triggers perinuclear
CC       arachidonate release and LTC4 synthesis in a PLA2G4A-independent way.
CC       In neutrophils, amplifies CysLTs biosynthesis initiated by PLA2G4A (By
CC       similarity). Promotes immune complex clearance in macrophages via
CC       stimulating synthesis of CysLTs, which act through CYSLTR1 to trigger
CC       phagocytosis. May regulate antigen processing in antigen-presenting
CC       cells. In pulmonary macrophages regulates IL33 production required for
CC       activation of group 2 innate lymphoid cells (By similarity). May play a
CC       role in the biosynthesis of N-acyl ethanolamines that regulate energy
CC       metabolism. Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl
CC       lysophosphatidylethanolamines, which are further cleaved by a
CC       lysophospholipase D to release N-acyl ethanolamines (By similarity).
CC       {ECO:0000250|UniProtKB:P39877, ECO:0000250|UniProtKB:P97391}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10035, ECO:0000255|PROSITE-
CC         ProRule:PRU10036};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15802;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-glycero-3-
CC         phosphocholine + H(+); Xref=Rhea:RHEA:38779, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:72998,
CC         ChEBI:CHEBI:73001; Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38780;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphocholine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphocholine + H(+);
CC         Xref=Rhea:RHEA:40427, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:72998, ChEBI:CHEBI:73003;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40428;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-
CC         phosphoethanolamine + H2O = (9Z,12Z)-octadecadienoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40815, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30245, ChEBI:CHEBI:73004, ChEBI:CHEBI:73008;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40816;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphoethanolamine + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1-
CC         hexadecanoyl-sn-glycero-3-phosphoethanolamine + H(+);
CC         Xref=Rhea:RHEA:40431, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:73004, ChEBI:CHEBI:73009;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40432;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phospho-(1D-myo-inositol) + H2O = (5Z,8Z,11Z,14Z)-eicosatetraenoate
CC         + 1-octadecanoyl-sn-glycero-3-phospho-(1D-myo-inositol) + H(+);
CC         Xref=Rhea:RHEA:41215, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32395, ChEBI:CHEBI:74243, ChEBI:CHEBI:133606;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41216;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoglycerol + H2O = (9Z)-octadecenoate + 1-hexadecanoyl-sn-
CC         glycero-3-phosphoglycerol + H(+); Xref=Rhea:RHEA:44524,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:84472, ChEBI:CHEBI:84475;
CC         Evidence={ECO:0000250|UniProtKB:P97391};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44525;
CC         Evidence={ECO:0000250|UniProtKB:P97391};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-hexadecanoyl-1,2-di-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphoethanolamine = (9Z)-octadecenoate + H(+) + N-hexadecanoyl-1-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine;
CC         Xref=Rhea:RHEA:45424, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:78097, ChEBI:CHEBI:85217;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45425;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1'-[1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho]-3'-[1-(9Z-
CC         octadecenoyl)-sn-glycero-3-phospho]-glycerol + H2O = (9Z)-
CC         octadecenoate + 1',3'-bis-[1-(9Z-octadecenoyl)-sn-glycero-3-phospho]-
CC         glycerol + H(+); Xref=Rhea:RHEA:40467, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:77256,
CC         ChEBI:CHEBI:77259; Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40468;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1',3'-bis[1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho]-
CC         glycerol + H2O = (9Z)-octadecenoate + 1'-[1,2-di-(9Z-octadecenoyl)-
CC         sn-glycero-3-phospho]-3'-[1-(9Z-octadecenoyl)-sn-glycero-3-phospho]-
CC         glycerol + H(+); Xref=Rhea:RHEA:40463, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30823, ChEBI:CHEBI:77253,
CC         ChEBI:CHEBI:77259; Evidence={ECO:0000250|UniProtKB:P39877};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40464;
CC         Evidence={ECO:0000250|UniProtKB:P39877};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000250|UniProtKB:P39877}.
CC   -!- PATHWAY: Lipid metabolism; leukotriene B4 biosynthesis.
CC       {ECO:0000250|UniProtKB:P39877}.
CC   -!- PATHWAY: Lipid metabolism; leukotriene C4 biosynthesis.
CC       {ECO:0000250|UniProtKB:P39877}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P97391}. Cell
CC       membrane {ECO:0000250|UniProtKB:P97391}. Cytoplasmic vesicle, phagosome
CC       {ECO:0000250|UniProtKB:P97391}. Recycling endosome
CC       {ECO:0000250|UniProtKB:P97391}. Golgi apparatus, cis-Golgi network
CC       {ECO:0000250|UniProtKB:P97391}. Golgi apparatus, trans-Golgi network
CC       {ECO:0000250|UniProtKB:P97391}.
CC   -!- PTM: This enzyme lacks one of the seven disulfide bonds found in
CC       similar PA2 proteins.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03763; AAA82112.1; -; mRNA.
DR   EMBL; AY651028; AAT68714.1; -; mRNA.
DR   EMBL; BC085745; AAH85745.1; -; mRNA.
DR   RefSeq; NP_058870.1; NM_017174.1.
DR   RefSeq; XP_006239201.1; XM_006239139.3.
DR   RefSeq; XP_008762432.1; XM_008764210.2.
DR   AlphaFoldDB; P51433; -.
DR   SMR; P51433; -.
DR   STRING; 10116.ENSRNOP00000022715; -.
DR   PaxDb; 10116-ENSRNOP00000022715; -.
DR   Ensembl; ENSRNOT00000022716.6; ENSRNOP00000022715.4; ENSRNOG00000016838.6.
DR   Ensembl; ENSRNOT00055039251; ENSRNOP00055031836; ENSRNOG00055022859.
DR   Ensembl; ENSRNOT00060055322; ENSRNOP00060045766; ENSRNOG00060031903.
DR   Ensembl; ENSRNOT00065037215; ENSRNOP00065030023; ENSRNOG00065021857.
DR   GeneID; 29354; -.
DR   KEGG; rno:29354; -.
DR   UCSC; RGD:62051; rat.
DR   AGR; RGD:62051; -.
DR   CTD; 5322; -.
DR   RGD; 62051; Pla2g5.
DR   eggNOG; KOG4087; Eukaryota.
DR   GeneTree; ENSGT00940000162222; -.
DR   HOGENOM; CLU_090683_3_0_1; -.
DR   InParanoid; P51433; -.
DR   OrthoDB; 638584at2759; -.
DR   PhylomeDB; P51433; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-RNO-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-RNO-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-RNO-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-RNO-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-RNO-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-RNO-1483166; Synthesis of PA.
DR   UniPathway; UPA00085; -.
DR   UniPathway; UPA00878; -.
DR   UniPathway; UPA00879; -.
DR   PRO; PR:P51433; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016838; Expressed in heart and 16 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0032009; C:early phagosome; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0032010; C:phagolysosome; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; IDA:RGD.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; IDA:RGD.
DR   GO; GO:0004623; F:phospholipase A2 activity; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0050482; P:arachidonic acid secretion; IDA:RGD.
DR   GO; GO:0035965; P:cardiolipin acyl-chain remodeling; ISS:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0019370; P:leukotriene biosynthetic process; IDA:RGD.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IBA:GO_Central.
DR   GO; GO:0090385; P:phagosome-lysosome fusion; ISS:UniProtKB.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISO:RGD.
DR   GO; GO:0006663; P:platelet activating factor biosynthetic process; IDA:RGD.
DR   GO; GO:1905036; P:positive regulation of antifungal innate immune response; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0090265; P:positive regulation of immune complex clearance by monocytes and macrophages; ISS:UniProtKB.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISS:UniProtKB.
DR   GO; GO:1903028; P:positive regulation of opsonization; ISS:UniProtKB.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:1905164; P:positive regulation of phagosome maturation; ISS:UniProtKB.
DR   GO; GO:0043030; P:regulation of macrophage activation; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; Phospholipase A2 domain; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR033112; PLipase_A2_Asp_AS.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR036444; PLipase_A2_dom_sf.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PHOSPHOLIPASE A2 FAMILY MEMBER; 1.
DR   PANTHER; PTHR11716:SF10; PHOSPHOLIPASE A2 GROUP V; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; Phospholipase A2, PLA2; 1.
DR   PROSITE; PS00119; PA2_ASP; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell membrane; Cytoplasmic vesicle; Disulfide bond; Endosome;
KW   Fatty acid metabolism; Golgi apparatus; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Membrane; Metal-binding; Phagocytosis;
KW   Phospholipid degradation; Phospholipid metabolism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..137
FT                   /note="Phospholipase A2 group V"
FT                   /id="PRO_0000022763"
FT   ACT_SITE        67
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        111
FT                   /evidence="ECO:0000250"
FT   BINDING         47
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         49
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         51
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   DISULFID        46..137
FT                   /evidence="ECO:0000250"
FT   DISULFID        48..64
FT                   /evidence="ECO:0000250"
FT   DISULFID        63..117
FT                   /evidence="ECO:0000250"
FT   DISULFID        70..110
FT                   /evidence="ECO:0000250"
FT   DISULFID        79..103
FT                   /evidence="ECO:0000250"
FT   DISULFID        97..108
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   137 AA;  15996 MW;  B21607EF741FA608 CRC64;
     MKRLLTLAWF LACSVPAVPG GLLELKSMIE KVTGKNAVKN YGFYGCYCGW GGHGTPKDGT
     DWCCRMHDRC YGLLEEKHCA IRTQSYDYRF TQDLVICEHD SFCPVRLCAC DRKLVYCLRR
     NLWSYNRLYQ YYPNFLC
//
